Jazz Pharmaceuticals will acquire GW Pharmaceuticals in a deal valued at $7.2 billion. Jazz Pharmaceuticals shares were down in premarket trading. Under terms of the agreement, Jazz will pay $220 ...
HC Wainwright & Co. has decided to maintain its Buy rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) and lower its price target from $204.00 to $200.00. Shares of Jazz Pharmaceuticals are trading up 0.2% ...
“It’s a huge breakthrough for the concept of cannabinoids as medicines,” says Justin Gover, CEO of manufacturer GW Pharmaceuticals. Next, the company is exploring how effective CBD and other ...
Following this announcement, GW Pharmaceuticals shares, which rose over 10% in 2020, jumped 49% to a record high of $217.5 on Wednesday. On the other hand, Jazz Pharmaceuticals shares seen its ...
Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex. Nasdaq-listed GW is in line for $220 ...
Jazz Pharmaceuticals (NASDAQ:JAZZ) entered the cannabis sector in 2021 when it acquired GW Pharmaceuticals, and it has since established its presence in cannabinoid science. Through its intensive ...
GW Pharmaceuticals, a British-based company focused on the development of cannabinoid based medications had a breakthrough this year when the FDA approved Epidiolex, a CBD-based drug derived from ...
The drug was added to Jazz’s portfolio with the GW Pharmaceuticals’ acquisition in 2021. Jazz is making significant progress related to the launch of Epidyolex in Europe and other ex-U.S. markets.
Nasdaq-traded marijuana stocks are undervalued as investors remain skittish and the use of drugs produced by these biopharmaceutical companies have not been widely adopted. Nasdaq-traded marijuana ...
In this article, we are going to discuss the 20 states with the cheapest weed in America. You can skip our detailed analysis ...
GW Pharmaceuticals is a cutting-edge UK-based biopharmaceutical company that over the last 20 years has established a world-leading position in cannabinoid science and the development of ...
Call It Reefer Magic? FDA-Approved Cannabis-Based Drug Epidiolex Now for Sale in All 50 States © 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site ...